Table 2. Proteins of HS serum granulations and nanobacteria identified by MALDI-TOF mass spectrometry.
# | Identified Proteinsa | MWb (kDa) | Serum Granulationsc | Nanobacteriad | |||
HS-1 | HS-2 | HS-3 | HS-4 | HS NB | |||
1 | Complement component 3 | 187 | 8 | 10 | 8 | 15 | 12 |
2 | Serum albumin | 69 | 11 | 8 | 5 | 6 | 14 |
3 | Apolipoprotein B100 | 516 | 8 | 6 | 11 | 8 | 6 |
4 | Complement component 4A | 193 | 7 | 4 | 4 | 7 | 6 |
5 | Apolipoprotein A1 | 31 | 2 | 8 | 6 | 5 | 4 |
6 | α2-macroglobulin | 163 | 3 | 4 | 5 | 1 | 10 |
7 | IGHM protein | 53 | 3 | 2 | 2 | 1 | 2 |
8 | Serotransferrin | 77 | 3 | 0 | 0 | 0 | 4 |
9 | Apolipoprotein A2 | 11 | 1 | 2 | 1 | 1 | 1 |
10 | Haptoglobin | 47 | 1 | 2 | 2 | 0 | 0 |
11 | Fetuin-A | 39 | 0 | 1 | 1 | 1 | 1 |
12 | Hemoglobin subunit β | 16 | 1 | 0 | 0 | 0 | 0 |
The numbers shown for each protein correspond to the amount of distinct peptides obtained for each protein which was divided by the total amount of distinct peptides identified in the first 50 proteins found in each sample. This value was then multiplied by 100 to give an indication of the relative abundance of each protein.
MW: molecular weight.
Serum granulations (pellets) were obtained from untreated HS (HS-1) or following addition of either CaCl2 (HS-2), Na2HPO4 (HS-3), or both (HS-4) as described in the Materials and Methods .
HS NB was obtained from human serum as described in the Materials and Methods .